Prescription drug · UNAPPROVED DRUG OTHER
Methenamine Mandelate NDC 62135-200
Methenamine mandelate 500 mg/1 · Tablet, Film coated · Oral · Chartwell RX, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 62135-200-01 | 62135020001 | 100 TABLET, FILM COATED in 1 BOTTLE (62135-200-01)Marketed from Oct 1, 2021 | |
| 62135-200-12 | 62135020012 | 120 TABLET, FILM COATED in 1 BOTTLE (62135-200-12)Marketed from Oct 1, 2021 | |
| 62135-200-60 | 62135020060 | 60 TABLET, FILM COATED in 1 BOTTLE (62135-200-60)Marketed from Oct 1, 2021 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Methenamine Mandelate
- Generic name (nonproprietary)
- methenamine mandelate
- Active ingredients
- Methenamine mandelate — 500 mg/1
- Dosage form
- Tablet, Film coated
- Route
- Oral
- Labeler
- Chartwell RX, LLC
- Product type
- Prescription drug
- Marketing category
- Unapproved drug (other)
- Marketing start
- Listing expires
- Identifiers
- Product ID 62135-200_00225fc8-eb0d-a4cc-e063-6394a90a2acbSPL ID 00225fc8-eb0d-a4cc-e063-6394a90a2acbSPL set ID 69efa19c-64a2-41cb-a298-6e9113e57fd7RxCUI 992153, 992184UNII 695N30CINRUPC 0362135201609, 0362135200121, 0362135200015, 0362135200602, 0362135201012, 0362135201128
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N462135020001followed by a unit qualifier and the quantityPackage 62135-0200-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Methenamine mandelate is indicated for the suppression or elimination of bacteriuria associated with pyelonephritis, cystitis, and other chronic urinary tract infections; also those neurologic diseases leading to an infected residual urine. When used as recommended, methenamine mandelate is particularly suitable for long-term therapy because of its safety and because resistance to the nonspecific bactericidal action of formaldehyde does not develop. Pathogens resistant to other antibacterial agents may respond to methenamine mandelate because of the nonspecific effect of formaldehyde formed in an acid urine. Prophylactic Use Rationale: Urine is a good culture medium for…
Excerpt only. Read the full label for complete information.